• US FDA approves Siliq to treat plaque psoriasis pharmaceutical-technology
    February 17, 2017
    FDA Center for Drug Evaluation and Research Office of Drug Evaluation III director Julie Beitz said: "Moderate-to-severe plaque psoriasis can cause significant skin irritation and discomfort for patients, and today’s approval provides patients with anothe
PharmaSources Customer Service